All Stories

  1. Recurrent integration of domestic cat hepatitis B virus DNA near feline CCNE1 supports an oncogenic role in hepatocellular carcinoma in cats
  2. Biology of hepatitis B virus DNA integration and its impact on antiviral R&D
  3. Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines
  4. Scientific and medical evidence informing expansion of hepatitis B treatment guidelines
  5. Let's break it down: combating hepatitis stigma and discrimination
  6. Sexual health and young people living with chronic hepatitis B: adopting a treatment as prevention framework
  7. Domestic Cat Hepadnavirus, a Hepatitis B-like Virus Associated with Feline Liver Disease
  8. Demographic factors, knowledge, and experiences associated with engagement in care in Australians diagnosed with hepatitis B
  9. Domestic cat hepadnavirus is detected infrequently in feline blood and liver samples submitted for diagnostic testing in Texas, USA
  10. Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024
  11. Best practices for engaging with affected communities: chronic hepatitis B as a case study
  12. The urgent need to end hepatitis B stigma and discrimination
  13. Novel digital droplet inverse PCR assay shows that natural clearance of hepatitis B infection is associated with fewer viral integrations
  14. HBV‐Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment
  15. Perspectives of People Living With Chronic Hepatitis D: Impact of Disease and Unmet Needs Along the Care Cascade
  16. Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis
  17. Major open questions in the hepatitis B and D field – Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop
  18. Peer support for people living with hepatitis B virus—A foundation for treatment expansion
  19. Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus
  20. Quality of life of people living with chronic hepatitis B: The role of social support system
  21. Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis
  22. Inhibition of Cellular Factor TM6SF2 Suppresses Secretion Pathways of Hepatitis B, Hepatitis C, and Hepatitis D Viruses
  23. Reply to Piewbang et al. Domestic Cat Hepadnavirus Antigens in Lymphoma Tissues. Comment on “Beatty et al. Domestic Cat Hepadnavirus and Lymphoma. Viruses 2023, 15, 2294”
  24. Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile
  25. Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?
  26. Domestic Cat Hepadnavirus and Lymphoma
  27. Special Issue “Hepatitis B Virus: New Breakthroughs to Conquer an Ancient Disease”
  28. Targeting Hepatitis B Virus DNA Using Designer Gene Editors
  29. Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B
  30. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  31. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  32. Targeting liver metabolism: a pathway to cure hepatitis B virus?
  33. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  34. Pathway to global elimination of hepatitis B: HBV cure is just the first step
  35. Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis B, Hepatitis C and Hepatitis D viruses
  36. Domestic Cat Hepadnavirus: Molecular Epidemiology and Phylogeny in Cats in Hong Kong
  37. Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus
  38. Prevalence and Genomic Sequence Analysis of Domestic Cat Hepadnavirus in the United States
  39. Mitosis of hepatitis B virus-infected cells in vitro results in uninfected daughter cells
  40. Stigma: a major barrier to hepatitis B elimination
  41. Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity
  42. Surrogate Markers for Hepatitis B Virus Covalently Closed Circular DNA
  43. Approaches to quantifying hepatitis B virus covalently closed circular DNA
  44. Viral integrations in chronic hepatitis B infection: Purposeless passenger or problematic promoter of persistence?
  45. A River From the Liver: Detecting Hepatocyte Genomic DNA in Urine
  46. The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research—Lessons in Scientific Community Outreach
  47. Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence
  48. De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA
  49. Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence
  50. A sensitive and Specific PCR-based Assay to Quantify Hepatitis B Virus Covalently Closed Circular (ccc) DNA While Preserving Cellular DNA
  51. Special Issue “Hepatitis B Virus Infection: From Diagnostics to Treatments”
  52. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance
  53. The evolution and clinical impact of hepatitis B virus genome diversity
  54. The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure
  55. Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver
  56. Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus
  57. Analyse chromosomal integrierter HBV-DNA durch inverse nested PCR
  58. Journal Watch: Dr Tu looks back at the most important research articles released in 2018 relating to models and biomarkers of hepatocellular carcinoma
  59. Hepatitis B virus (HBV) DNA integration is not driven by viral proteins
  60. Detection of Low Copy Number Integrated Viral DNA Formed by <em>In Vitro</em> Hepatitis B Infection
  61. Detection of Low Copy Number Integrated Viral DNA Formed by <em>In Vitro</em> Hepatitis B Infection
  62. Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion
  63. Cellular Genomic Sites of Hepatitis B Virus DNA Integration
  64. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
  65. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
  66. Hepatitis B virus integration into cellular genome
  67. HBV bypasses the innate immune system and does not protect HCV against the antiviral effect of IFN
  68. HBV DNA Integration: Molecular Mechanisms and Clinical Implications
  69. Chronic viral hepatitis and its association with liver cancer
  70. Integrated analysis of exosomal microRNA, gene, and pathway regulatory networks in fibrosis and hepatocarcinogenesis
  71. Viral Hepatitis
  72. Whole genome sequencing analysis of familial primary sclerosing cholangitis
  73. Detection of Hepatocyte Clones Containing Integrated Hepatitis B Virus DNA Using Inverse Nested PCR
  74. Basic Science Liver
  75. Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma
  76. Abstracts of the 25th Annual Conference of APASL, February 20–24, 2016, Tokyo, Japan
  77. Differential Microrna Expression in Plasma Microvesicles Predict Hepatocellular Carcinoma Regulatory Pathways
  78. Multi-Omics Landscape of Precancerous Liver Disease
  79. Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?
  80. Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays
  81. Basic Science - Liver
  82. P0268 : Accumulation of deleterious passenger mutations during liver injury progression to hepatocellular carcinoma
  83. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma
  84. Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection
  85. Our experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology
  86. Poster Presentation Abstracts
  87. Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis
  88. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
  89. Advances in and the future of treatments for hepatitis C
  90. Endoscopy Upper
  91. “Testing your methyl”: DNA methylation profiling of serum DNA of HCC patients